Skip to content

BrettMaas.com

Communicating your story to the Street

Roth says this biopharma stock has room to run on drug momentum, upcoming trial catalysts

Roth’s $212 price target implies an additional upside of 32% for shares of Insmed, which have already rallied 160% in the last 12 months.

Author Posted on January 23, 2026Categories Uncategorized

Intel’s earnings beat couldn’t offset a weaker-than-expected outlook. Here’s what analysts are saying

For the most part, Wall Street analysts maintained a hold-equivalent rating on Intel after supply constraints weighed on the company’s current-quarter outlook.

Author Posted on January 23, 2026Categories Uncategorized

Friday’s big stock stories: What’s likely to move the market in the next trading session

The three major averages jumped for a second consecutive session Thursday, with the Dow Industrials wiping out the week’s losses.

Author Posted on January 22, 2026Categories Uncategorized

Where this top Fidelity bond manager is investing for 2026

Celso Muñoz is among what Morningstar calls the “best-in-class” bond fund managers at Fidelity. Here is where he sees opportunity for income-oriented investors.

Author Posted on January 22, 2026Categories Uncategorized

Analysts are growing more bullish on these stocks, including a major trading platform

A few names have received three or more positive stock ratings since the end of 2025, suggesting the Street is becoming bullish on them.

Author Posted on January 22, 2026Categories Uncategorized

Time to buy the dip in volatile quantum stocks, says B. Riley. These are the firm’s favorites

The firm reiterated its buy ratings on IonQ and D-Wave Quantum, and upgraded its rating on another leading pure-play quantum stock.

Author Posted on January 22, 2026Categories Uncategorized

Charts point to rotation to chips from software inside the technology universe

The key question now is how much worse can it get for software when areas like semiconductors are pushing to new all-time highs.

Author Posted on January 22, 2026Categories Uncategorized

This financial stock reporting after the bell has been a winning trade for 13-straight earnings reports

When the credit card lender reports results Thursday, traders will be watching not just the numbers, but whether the company can extend an unusual streak.

Author Posted on January 22, 2026Categories Uncategorized

A lot of bad news is priced into Lululemon. Trading the athleisure giant using options

Founder Chip Wilson’s activism may be helpful — and he has plenty of motivation to see things turn around.

Author Posted on January 22, 2026Categories Uncategorized

This solar stock in Josh Brown’s Best Stocks list could soon break out to 20-year highs

Josh Brown and Sean Russo take readers through this solar panel manufacturer.

Author Posted on January 22, 2026Categories Uncategorized

Posts navigation

Previous page Page 1 … Page 134 Page 135 Page 136 … Page 690 Next page

RSS MarketWatch: Stock Market News

  • Tesla and Waymo duel in the robotaxi race — but the company spending the most builds no cars at all June 25, 2026
    Uber is quietly writing $500 million checks to lock in robotaxis as Waymo threatens to leave it behind.
    Jurica Dujmovic
  • Why getting dumped from the Dow is the ultimate buy signal for this — or any — stock June 25, 2026
    The “Dow curse” now favors Verizon over Alphabet.
    Mark Hulbert
  • Take a cue from the rich: Do a midyear financial check-in June 25, 2026
    Financial advisers would tell you to rebalance your portfolio at a midyear check-in. Make these 4 money moves instead.
    Beth Pinsker
  • SpaceX stock is a terrible buy — what that actually means for the bull market June 25, 2026
    Overhyped IPOs rarely make you money in the short term. That doesn’t mean it’s time to sell your stocks..
    Robert Ross
  • Iran tightens its grip on Strait of Hormuz, sending oil higher June 25, 2026
    Oil risks fresh shocks as Iran appears to assert control over the passageway.
    Claudia Assis
  • ‘It feels like a medical miracle’: How did a single QR code coupon cut my $618 Walgreens prescription to $15? June 25, 2026
    “This medication was generic.”
    Quentin Fottrell
  • This disease is more expensive than cancer and heart disease combined. And it’s only going to get worse. June 25, 2026
    “People should be alarmed. This is a health crisis. It’s also an economic crisis for families and government,”
    Jessica Hall
  • Bayer’s stock jumps after Supreme Court sides with Roundup weedkiller manufacturer June 25, 2026
    The court ruled that states cannot have differing labeling warning rules than federal law requires.
    Nora Redmond
  • A relative offered me a $25,000 home loan secured by a lien that must be repaid within a year. Is that fair? June 25, 2026
    “He also wants me to downsize and move.”
    Quentin Fottrell
  • ‘Take the money while you can’: I’m a CPA and tell my clients to take their Social Security early. Am I wrong? June 25, 2026
    “Only 8% to 10% of people wait until age 70 to claim.”
    Quentin Fottrell

Tags

  • (Nasdaq:ICLK)
  • Apple
  • Apple iPad
  • BrettMaas
  • Brett Maas
  • brett maas charities
  • brett maas gives back
  • brett maas hayden
  • brett maas hayden ir
  • brett maas investor relations
  • brett maas twitter
  • BSQR
  • Bsquare
  • BSquare Corporation
  • bulletin board stocks
  • Cover-All Technologies
  • DOW
  • Echo Therapeutics
  • Forbes
  • Ford
  • Ford Motor Company
  • global axcess corporation
  • Google
  • Green Technology
  • Hayden IR
  • ICLK
  • Interclick
  • investor relations
  • iOS5
  • iPhone
  • IPOs
  • New Cardio
  • NY Daily News
  • online search
  • PHC
  • Recession
  • Samsung
  • Sarah Palin
  • Semler Scientific
  • small cap stocks
  • smlr
  • Tiger Woods
  • Twitter
  • Venture Capital
  • yahoo

Blogroll

  • Brett Maas Social Sites
  • DIAP Media, Phoenix SEO

Links

  • Brett Maas
  • Brett Maas Blog
  • Brett Maas Charity Site
  • Brett Maas Real Estate
  • CEO Express
  • Tailor in Phoenix I use
BrettMaas.com Proudly powered by WordPress